Portfolio
Project Decription
ESCAPE-NEXT is a multicentre, randomized, double-blinded, placebo-controlled, parallel Group, singledose trial designed to determine the efficacy and safety of nerinetide in participants with
Project Decription
One of the first projects on our DCTMS platform, the Alberta Hope COVID-19 Trial was a province-wide lead by researchers at the University of Calgary and the Univeristy of Edmonton to investi
Project Decription
One of the first projects on our DCTMS platform, the AcT trial is a Pragmatic Phase III randomized open-label registry-based trial with blinded end-point assessment. The trial seeks to test w